Molecular biomarkers as key determinants of outcome in mantle cell lymphoma: results from the FIL V-RBAC trial.
Moia R, Almasri M, Carazzolo ME, Cividini L, Tabanelli V, Melle F, Genuardi E, Cosentino C, Maher N, Bellia M, Mahmoud AM, Evangelista A, Quaglia FM, Fiori S, Bomben R, Tisi MC, Riva M, Merli A, Di Rotondo F, Corradini P, Farina L, Castellino C, Castellino A, Zilioli VR, Muzi C, Piazza F, Re A, Hohaus S, Rossi Dardanoni FG, Musuraca G, Di Rocco A, Puccini B, Sciarra R, Ballerini F, Cavallo F, Bruna R, Moioli A, Bernardelli A, Patti C, Olivieri J, Bianchi B, Loseto G, Spina M, Usai SV, Stefani PM, Stelitano C, Drandi D, Zinzani PL, Ferreri AJM, Balzarotti M MD, Ladetto M, Ferrero S, Pileri SA, Gaidano G, Visco C.
Moia R, et al. Among authors: melle f.
Blood Adv. 2026 Jul 24:bloodadvances.2026020780. doi: 10.1182/bloodadvances.2026020780. Online ahead of print.
Blood Adv. 2026.
PMID: 42498280